Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (41,028) $ (47,770)
Reconciling items:    
Depreciation 42,137 35,912
Amortization 45,734 44,620
Amortization of non-recoupable ticketing contract advances 19,945 20,063
Non-cash compensation expense 10,870 7,936
Other, net 6,166 2,410
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (53,080) (6,558)
Increase in prepaid expenses and other assets (405,036) (311,447)
Increase in accounts payable, accrued expenses and other liabilities 52,318 56,600
Increase in deferred revenue 1,097,472 959,971
Net cash provided by operating activities 775,498 761,737
CASH FLOWS FROM INVESTING ACTIVITIES    
Investments made in nonconsolidated affiliates (2,997) (10,608)
Purchases of property, plant and equipment (45,125) (58,881)
Cash paid for acquisitions, net of cash acquired (20,222) (4,700)
Purchases of intangible assets (25,914) (605)
Other, net 5,532 (233)
Net cash used in investing activities (88,726) (75,027)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 856,660 932
Payments on long-term debt (321,850) (11,775)
Distributions to noncontrolling interests (19,523) (12,227)
Purchases and sales of noncontrolling interests, net (104,233) (5,098)
Proceeds from exercise of stock options 7,922 21,628
Payments for deferred and contingent consideration (11,780) (1,074)
Other, net (3,046) 2,547
Net cash provided by (used in) financing activities 404,150 (5,067)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 29,039 20,356
Net increase in cash, cash equivalents and restricted cash 1,119,961 701,999
Cash, cash equivalents and restricted cash at beginning of period 1,828,822 1,529,575
Cash, cash equivalents and restricted cash at end of period $ 2,948,783 $ 2,231,574